Non-major bleeding risk of direct oral anticoagulants versus vitamin K antagonists for stroke prevention with atrial fibrillation: a systematic review and network meta …

F Ma, W Xu, J Chen, J Zhang - European Journal of Clinical …, 2023 - Springer
Abstract Background Direct oral anticoagulants (DOACs) are associated with bleeding.
Patients often stop taking DOACs due to non-major bleeding, which may lead to stroke …
被引用次数：2 相关文章

Non-major bleeding risk of direct oral anticoagulants versus vitamin K antagonists for stroke prevention with atrial fibrillation: a systematic review and network meta …

F Ma, W Xu, J Chen, J Zhang - European Journal of Clinical …, 2023 - europepmc.org
Background Direct oral anticoagulants (DOACs) are associated with bleeding. Patients often
stop taking DOACs due to non-major bleeding, which may lead to stroke recurrence. We …

Non-major bleeding risk of direct oral anticoagulants versus vitamin K antagonists for stroke prevention with atrial fibrillation: a systematic review and network meta …

F Ma, W Xu, J Chen, J Zhang - European journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Direct oral anticoagulants (DOACs) are associated with bleeding. Patients often
stop taking DOACs due to non-major bleeding, which may lead to stroke recurrence. We …

Non-major bleeding risk of direct oral anticoagulants versus vitamin K antagonists for stroke prevention with atrial fibrillation: a systematic review and network meta …

F Ma, W Xu, J Chen, J Zhang - 2023 - cabidigitallibrary.org
Abstract Background: Direct oral anticoagulants (DOACs) are associated with bleeding.
Patients often stop taking DOACs due to non-major bleeding, which may lead to stroke …